US clinical-stage biotech CARGO Therapeutics’ shares plummeted more than 75% to $3.23 yesterday, after it announced that it ...

Capt. Matt Wells, the program manager for Oklahoma Task Force 1, shared with 2 News Oklahoma's Brodie Myers, the intricacies ...

NEW YORK CITY, NY / ACCESS Newswire / January 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CARGO ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CARGO Therapeutics, Inc. ("CARGO" or "the Company") for ...

Right now shoppers can grab the Nike Air Force 1 '07 for as low as $70 and the Nike Air Force 1 Shadow for as low as $82.

One reviewer says, "Worth the Wait – Amazing Sound and Stunning Design!" ...

LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

The changes will extend the company's cash runway, enabling it to advance a tri-specific CAR T-cell candidate and its allogeneic cell therapy platform.

Benchmark upgraded Meta Platforms (META) to Buy from Hold with a $820 price target, citing a "strong" 2025 core business ...

JPMorgan analyst Brian Cheng downgraded Cargo Therapeutics (NASDAQ:CRGX) stock from Neutral to Underweight following the company's disappointing clinical trial results. The $607 million market cap ...

Investing.com -- Shares of CARGO Therapeutics , Inc. (NASDAQ: CRGX) plummeted 75% following the company's decision to discontinue its Phase 2 clinical trial for firicabtagene autoleucel, citing ...